<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 is the most common chromosomal gain in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), however, little is known about the features of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with isolated <z:mp ids='MP_0004027'>trisomy</z:mp> 8 and the influence of additional cytogenetic aberrations </plain></SENT>
<SENT sid="1" pm="."><plain>We determined the characteristics and prognostic factors of 72 patients with <z:mp ids='MP_0004027'>trisomy</z:mp> 8 as a single anomaly and analysed also the impact of other aberrations added to <z:mp ids='MP_0004027'>trisomy</z:mp> 8 in another 62 patients </plain></SENT>
<SENT sid="2" pm="."><plain>According to our study, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with isolated <z:mp ids='MP_0004027'>trisomy</z:mp> 8 was more frequent in men, with more than one cytopenia in most patients (62%) and having about 4% bone marrow blasts </plain></SENT>
<SENT sid="3" pm="."><plain>The multivariate analysis demonstrated that platelet count and percentage bone marrow blasts had the strongest impact on overall survival (OS) </plain></SENT>
<SENT sid="4" pm="."><plain>The median OS for isolated <z:mp ids='MP_0004027'>trisomy</z:mp> 8, <z:mp ids='MP_0004027'>trisomy</z:mp> 8 plus one aberration (tr8 + 1), plus two (tr8 + 2) and plus three or more aberrations (tr8 + ≥3) was 34·3, 40, 23·4 and 5·8 months, respectively (P &lt; 0·001) </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 confers a poorer prognosis than a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with ≥5% bone marrow blasts </plain></SENT>
<SENT sid="6" pm="."><plain>This study supports the view that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with isolated <z:mp ids='MP_0004027'>trisomy</z:mp> 8 should be included in the intermediate cytogenetic risk group </plain></SENT>
</text></document>